C-Mer Eye Holdings

Venture Capital Active Hong Kong
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$12.3M
total disclosed, rounds participated
Stages
—

Portfolio · 1

BELKIN Vision
One-second Laser Treatment for Glaucoma
1 round $12.3M committed Latest: 2020-07

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is C-Mer Eye Holdings' most notable exit?
C-Mer Eye Holdings notably exited BELKIN Vision in July 2024 through an acquisition by Alcon Pharmaceuticals for $81M.
Which sectors does C-Mer Eye Holdings focus on for investments?
C-Mer Eye Holdings shows a concentration in the Health Tech & Life Sciences sector, with all its portfolio companies and exits falling within this area.
When did C-Mer Eye Holdings make its most recent investment?
C-Mer Eye Holdings made its most recent recorded investment in July 2020.
What is the primary business model of C-Mer Eye Holdings' portfolio companies?
C-Mer Eye Holdings' portfolio company, BELKIN Vision, operates on a B2B business model.
What is the typical investment stage for C-Mer Eye Holdings?
C-Mer Eye Holdings has participated in B Round funding stages, as seen with its investment in BELKIN Vision.
What is the total amount raised by BELKIN Vision, a portfolio company of C-Mer Eye Holdings?
BELKIN Vision, a portfolio company of C-Mer Eye Holdings, raised $38.44M prior to its acquisition.